| Bone union, HRa (95.0% CI) | p-value | > 2 years revisions, HRa (95.0% CI) | p-value |
---|---|---|---|---|
Univariate analysis | ||||
 Gender (male) | 1.06 (0.56–1.99) | 0.860 | 1.29 (0.38–4.32) | 0.672 |
 Age (years)b | 0.99 (0.96–1.02) | 0.460 | 1.01 (0.9–1.05) | 0.790 |
 Resection length (mm)b | 1.00 (0.94–1.06) | 0.967 | 0.98 (0.87–1.10) | 0.705 |
 Irradiated allograft | 0.68 (0.35–1.32) | 0.256 | 3.57 (1.12–11.48) | 0.031 |
 Adjuvant radiotherapy | 0.32 (0.09–1.05) | 0.061 | 2.63 (0.72–9.71) | 0.144 |
 Adjuvant chemotherapy | 1.05 (0.51–2.14) | 0.894 | 1.10 (0.33–4.55) | 0.759 |
 Diagnosisc | ||||
  CHS (cref.) |  | 0.841 |  | 0.661 |
  OS | 0.75 (0.28–1.98) | 0.556 | 0.48 (0.14–1.67) | 0.251 |
  Ewing’s | 0.84 (0.29–2.43) | 0.742 | 1.20 (0.14–11.11) | 0.866 |
 Associated graft | ||||
  VFG−: TG (cref.) |  | 0.026 |  | 0.025 |
  CBG | 1.98 (0.85–4.49) | 0.112 | 0.25 (0.03–2.00) | 0.192 |
  VFG+ | 2.64 (1.28–5.44) | 0.008 | 0.17 (0.04–0.80) | 0.024 |
 Stabilisation | ||||
  Nail (cref.) |  | 0.149 |  | 0.095 |
  Plate | 1.17 (0.54–2.51) | 0.690 | 0.79 (0.13–4.98) | 0.814 |
  Nail + plate | 0.59 (0.27–1.30) | 0.191 | 3.38 (0.83–12.82) | 0.090 |
Multivariate analysis | Model p-value = 0.003 | Â | Model p-value = 0.010 | Â |
Adjuvant RT | 0.21 (0.06–0.74) | 0.015 | 5.91 (1.19–29.38) | 0.030 |
Irradiated allograft |  |  | 6.00 (1.49–24.22) | 0.012 |
Associated graft: VFG−: TG (cref.) |  | 0.004 |  |  |
 CBG | 1.89 (0.80–4.44) | 0.145 |  |  |
 VFG+ | 3.81 (1.68–8.64) | 0.001 |  |  |